Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Boundless Bio, Inc. BOLD

Set alert

Price alert · BOLD

All alert types
2.43 USD -0.04 -1.62%

As of Nov 2, 2:10 PM ET

Bid
2.42 × 1
Ask
2.43 × 1
2.40 Day range 2.50
0.961 52-week range 3.16
YTD
+102.50%
1 year
+73.57%
Open
2.48
Prev close
2.47
Mkt cap
56.15M
Vol
63.46K
Avg vol
178.10K
EPS
-2.85
P/E
0.00
Div yield
0.00%
More statistics
Low
2.40
High
2.50
Forward P/E
-0.70
Beta
0.00
Short ratio
2.01
Inst. own
75.86%
Dividend
0.00
Ex-div date
Earnings
Feb 6, 2025
50-d avg
2.91
200-d avg
5.46
1y target
14.50

3M chart

Chart tools
Interval
1m5m15m30m

Signals (11)
NameDateAgo
MACD: Buy SignalOct 26, 20261 week ago
RSI: OversoldOct 15, 20262 weeks ago
SMA: BearishSep 23, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
MACD: Sell SignalAug 25, 20262 months ago
MACD: Buy SignalAug 21, 20262 months ago
RSI: OverboughtAug 18, 20262 months ago
MACD: Sell SignalAug 13, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago
RSI: OverboughtAug 4, 20263 months ago

Financial health

Altman Z-Score

-3.09 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -0.5×
FY 2016: -2.5×FY 2017: -4.2×FY 2018: -4.9×FY 2021: -12.6×FY 2022: -6.9×FY 2023: -6.4×FY 2024: -0.8×FY 2025: -0.5×
FY 2016 5y median -6.4× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.3×
FY 2016: 1.3×FY 2017: 2.4×FY 2018: 1.4×FY 2021: -8.3×FY 2022: -3.9×FY 2023: -2.5×FY 2024: 0.3×FY 2025: 0.3×
FY 2016 5y median -2.5× FY 2025
P/FCF -0.6×
FY 2016: -2.3×FY 2017: -4.1×FY 2018: -5.2×FY 2021: -12.5×FY 2022: -7.8×FY 2023: -6.7×FY 2024: -0.8×FY 2025: -0.6×
FY 2016 5y median -6.7× FY 2025
EV/EBITDA -1.0×
FY 2016: -2.0×FY 2017: -3.9×FY 2018: -4.0×FY 2021: -11.5×FY 2022: -6.9×FY 2023: -6.1×FY 2024: -1.1×FY 2025: -1.0×
FY 2016 5y median -6.1× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -175.9%
FY 2016: -43.2%FY 2017: -24.3%FY 2018: -19.1%FY 2021: -8.0%FY 2022: -12.8%FY 2023: -15.0%FY 2024: -128.7%FY 2025: -175.9%
FY 2016 5y median -15.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -59.0%
FY 2016: -50.0%FY 2017: -57.6%FY 2018: -29.1%FY 2021: 66.0%FY 2022: 56.2%FY 2023: 38.9%FY 2024: -43.4%FY 2025: -59.0%
FY 2016 5y median 38.9% FY 2025
ROIC -43.0%
FY 2016: -46.3%FY 2017: -54.9%FY 2018: -29.8%FY 2021: -23.0%FY 2022: -65.0%FY 2023: -44.6%FY 2024: -37.0%FY 2025: -43.0%
FY 2016 5y median -43.0% FY 2025
ROA -37.1%
FY 2016: -42.0%FY 2017: -50.5%FY 2018: -27.3%FY 2021: -22.2%FY 2022: -59.7%FY 2023: -38.1%FY 2024: -31.7%FY 2025: -37.1%
FY 2016 5y median -37.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 13.3%
FY 2016: 0.0%FY 2017: -55.2%FY 2018: -44.2%FY 2021: 0.0%FY 2022: -83.7%FY 2023: -17.9%FY 2024: -33.7%FY 2025: 13.3%
FY 2016 FY 2025
EPS (diluted) 32.5%
FY 2016: 0.0%FY 2017: 39.2%FY 2018: 13.8%FY 2021: 0.0%FY 2022: -82.3%FY 2023: -7.8%FY 2024: -73.4%FY 2025: 32.5%
FY 2016 FY 2025
Free Cash Flow 25.5%
FY 2016: 0.0%FY 2017: -40.2%FY 2018: -29.9%FY 2021: 0.0%FY 2022: -60.8%FY 2023: -16.8%FY 2024: -33.5%FY 2025: 25.5%
FY 2016 FY 2025

Financial Health

Current Ratio 8.7×
FY 2016: 8.6×FY 2017: 7.7×FY 2018: 17.6×FY 2021: 19.3×FY 2022: 8.8×FY 2023: 13.3×FY 2024: 19.0×FY 2025: 8.7×
FY 2016 5y median 13.3× FY 2025
Quick Ratio 8.7×
FY 2016: 8.6×FY 2017: 7.7×FY 2018: 17.6×FY 2021: 19.3×FY 2022: 8.8×FY 2023: 13.3×FY 2024: 19.0×FY 2025: 8.7×
FY 2016 5y median 13.3× FY 2025
Debt / Equity 0.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2021: -0.0×FY 2022: -0.1×FY 2023: -0.0×FY 2024: 0.3×FY 2025: 0.5×
FY 2016 5y median -0.0× FY 2025
Net Debt / EBITDA -0.5×
FY 2016: 0.6×FY 2017: 0.4×FY 2018: 1.1×FY 2021: 1.4×FY 2022: 0.1×FY 2023: 0.4×FY 2024: -0.3×FY 2025: -0.5×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31